Valuation GlaxoSmithKline Pharmaceuticals Limited

Stocks

Market Closed - Bombay S.E. 11:02:24 13/08/2026 BST			5-day change	1st Jan Change
2,664.65 ^INR	+1.72%		+3.82%	+7.84%

08-03	GSK India first-quarter profit rises on steady vaccine demand	RE
08-03	GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	281,714	224,319	329,173	487,432	386,822	451,408	-
Change	-	-20.37%	46.74%	48.08%	-20.64%	16.7%	-
Enterprise Value (EV)	256,351	207,663	329,173	487,432	386,822	451,408	451,408
Change	-	-18.99%	58.51%	48.08%	-20.64%	16.7%	0%
P/E	16.6x	36.7x	55.8x	52.5x	37.3x	38.9x	33.8x
PBR	10.6x	12.9x	18.5x	25x	17.1x	17.1x	14.3x
PEG	-	-0.6x	-16.49x	0.9x	3.2x	3.2x	2.2x
Capitalization / Revenue	8.59x	6.9x	9.53x	13x	10.1x	10.6x	9.57x
EV / Revenue	0x	0x	0x	0x	0x	10.6x	9.57x
EV / EBITDA	0x	0x	0x	0x	0x	30.5x	26.5x
EV / EBIT	0x	0x	0x	0x	0x	30.9x	26.5x
EV / FCF	0x	0x	0x	0x	0x	37.6x	34.3x
FCF Yield	2.75%	1.96%	1.67%	2.6%	2.19%	2.66%	2.92%
Dividend per Share ²	30	32	32	42	57	29.5	29.5
Rate of return	1.8%	2.42%	1.65%	1.46%	2.5%	1.11%	1.11%
EPS ²	100	36.05	34.83	54.76	61.15	68.52	78.88
Distribution rate	30%	88.8%	91.9%	76.7%	93.2%	43%	37.4%
Net sales ¹	32,780	32,517	34,537	37,492	38,217	42,528	47,167
EBITDA ¹	8,273	8,043	9,087	11,774	13,092	14,794	17,020
EBIT ¹	7,592	7,385	8,390	11,106	12,428	14,621	17,016
Net income ¹	16,947	6,107	5,900	9,276	10,360	11,611	13,364
Net Debt	-25,363	-16,656	-	-	-	-	-
Reference price ²	1,662.95	1,324.15	1,943.10	2,877.30	2,283.40	2,664.65	2,664.65
Nbr of stocks (in thousands)	169,406	169,406	169,406	169,406	169,406	169,406	-
Announcement Date	16/05/22	17/05/23	17/05/24	13/05/25	13/05/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED	38.23x	-	-	1.13%	4.65B
ELI LILLY AND COMPANY	34.6x	12.64x	25.73x	0.57%	1,088B
JOHNSON & JOHNSON	29.02x	-	-	2.06%	629B
ABBVIE INC.	31.76x	7.4x	15.37x	2.76%	440B
ROCHE HOLDING AG	20.37x	4.83x	11.97x	2.73%	359B
NOVARTIS AG	21.72x	5.63x	14.03x	2.85%	291B
ASTRAZENECA PLC	20.24x	4.18x	11.87x	2.1%	245B
AMGEN INC.	26.11x	6.86x	12.2x	2.42%	225B
NOVO NORDISK A/S	13.56x	4.86x	10.12x	3.76%	204B
GILEAD SCIENCES, INC.	-42.19x	6.04x	34.06x	2.43%	168B
Average	19.34x	6.55x	16.92x	2.28%	365.39B
Weighted average by Cap.	24.67x	8.26x	18.73x	1.96%